Line 1
Molecular basis of tumour progression and therapy resistance
Tumour microenvironment, tumour immunology, biomarkers, therapy resistance, experimental models.
Line 2
Biomarkers and precision medicine in genitourinary cancer
Tumour genomics, liquid biopsy, prognostic and predictive biomarkers, AI and clinical stratification tools.
Line 3
Therapeutic innovation and clinical research in uro-oncology
Clinical trials, multicentre studies, clinical validation, precision medicine and evaluation of new therapeutic strategies.
